UroGen Pharma Ltd. (URGN) Form 144 Filed on June 9
Published on 6/9/2026
AI Summary
Summarized by AI from the source belowUroGen Pharma Ltd. (URGN) filed Form 144 on June 9 for potential transactions involving the sale of shares by insiders. This filing allows for the sale of shares under specific restrictions, which could influence the stock's liquidity. The current trading volume and any changes in share ownership following this filing are relevant for investor sentiment. Monitoring such regulatory filings helps investors gauge potential stock movements and insider activity.
Get the free market brief
Top stories and analysis, summarized. No spam, unsubscribe anytime.
Related News
Markets
GE HealthCare (GEHC) and Medtronic (MDT) Options Bets Recommend Decline
Sep 4
Markets
Volkswagen (VWAGY) Plans 50,000 Job Cuts Amid 8% Share Surge
Sep 4
Markets
Stocks Making Big Moves: AMC, USA Rare Earth, Lululemon, Adobe
Sep 4
Markets
Norway's Sovereign Wealth Fund Plans to Cut U.S. Treasury Holdings
Sep 4